Nicholas Leupin

Nicholas Leupin

Former Chief Medical OfficeratNovoCure· In the 2025 proxy

Pay in FY2025NovoCure stock -56.6% the same year

Nicholas Leupin was paid $4.0M in FY2025 (Dec). NovoCure stock fell 56.6% that year.

Pay$100 in the stock at the end of FY24 → $43
Pay is from the Summary Compensation Table of each NovoCure proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NovoCurePublic company · 1 yr
    • Former Chief Medical Officer2025 – Present · 1 yrStock in role -54%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?